Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1450453

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1450453

North America Tocotrienol Market Size, Share & Trends Analysis Report By Product (Alpha, Beta, Gamma, and Delta), By End Use (Dietary Supplement, Pharmaceuticals, Cosmetics, and Others), By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES:
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The North America Tocotrienol Market would witness market growth of 5.2% CAGR during the forecast period (2023-2030).

Dietary supplements cater to a diverse range of consumer preferences and health goals within the tocotrienol market. Some individuals may seek tocotrienol supplements for their antioxidant properties to combat oxidative stress and support overall cellular health. Others may be interested in tocotrienols for their potential benefits in promoting cardiovascular health, reducing inflammation, or supporting cognitive function.

Moreover, tocotrienols have garnered interest in pharmaceutical research due to their potential therapeutic properties. Studies suggest that tocotrienols may exhibit anti-inflammatory, antioxidant, and neuroprotective effects, making them promising candidates for the prevention and treatment of various diseases, including cardiovascular diseases, cancer, neurodegenerative disorders, and metabolic syndromes. Additionally, tocotrienols are being investigated for their role in modulating lipid metabolism, reducing cholesterol levels, and improving cardiovascular health. Clinical trials are exploring their efficacy in managing conditions such as hypercholesterolemia, atherosclerosis, and hypertension.

The high rate of chronic diseases in Canada underscores the importance of preventive healthcare strategies and the growing demand for natural health solutions like tocotrienols. According to Statistics Canada, 45.1% of Canadians lived with at least one major chronic disease in 2021. Thus, the expansion of the cosmetics and personal care products industry and the high rates of chronic diseases in the region are propelling the growth of the market.

The US market dominated the North America Tocotrienol Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $173,735.8 Thousands by 2030. The Canada market is experiencing a CAGR of 6.8% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 6.9% during (2023 - 2030).

Based on Product, the market is segmented into Alpha, Beta, Gamma, and Delta. Based on End Use, the market is segmented into Dietary Supplement, Pharmaceuticals, Cosmetics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Parchem Fine and Specialty Chemicals, Inc.
  • BASF SE
  • Eisai Co., Ltd.
  • Cayman Chemical Company, Inc.
  • Excelvite SDN. BHD.
  • BTSA BIOTECNOLOGIAS APLICADAS S.L.
  • American River Nutrition, LLC
  • Vance Group Ltd.
  • Kuala Lumpur Kepong Berhad (Davos Life Science)
  • SourceOne Global Partners

North America Tocotrienol Market Report Segmentation

By Product

  • Alpha
  • Beta
  • Gamma
  • Delta

By End Use

  • Dietary Supplements
  • Pharmaceuticals
  • Cosmetics
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1North America Tocotrienol Market, by Product
    • 1.4.2North America Tocotrienol Market, by End Use
    • 1.4.3North America Tocotrienol Market, by Country
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Restraints
    • 3.2.3Market Opportunities
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.North America Tocotrienol Market, by Product

  • 4.1North America Alpha Market, by Country
  • 4.2North America Beta Market, by Country
  • 4.3North America Gamma Market, by Country
  • 4.4North America Delta Market, by Country

Chapter 5.North America Tocotrienol Market, by End-use

  • 5.1North America Dietary Supplements Market, by Country
  • 5.2North America Pharmaceuticals Market, by Country
  • 5.3North America Cosmetics Market, by Country
  • 5.4North America Others Market, by Country

Chapter 6.North America Tocotrienol Market, by Country

  • 6.1US Tocotrienol Market
    • 6.1.1US Tocotrienol Market, by Product
    • 6.1.2US Tocotrienol Market, by End-use
  • 6.2Canada Tocotrienol Market
    • 6.2.1Canada Tocotrienol Market, by Product
    • 6.2.2Canada Tocotrienol Market, by End-use
  • 6.3Mexico Tocotrienol Market
    • 6.3.1Mexico Tocotrienol Market, by Product
    • 6.3.2Mexico Tocotrienol Market, by End-use
  • 6.4Rest of North America Tocotrienol Market
    • 6.4.1Rest of North America Tocotrienol Market, by Product
    • 6.4.2Rest of North America Tocotrienol Market, by End-use

Chapter 7.Company Profiles

  • 7.1Parchem Fine and Specialty Chemicals, Inc.
    • 7.1.1Company Overview
    • 7.1.2SWOT Analysis
  • 7.2BASF SE
    • 7.2.1Company Overview
    • 7.2.2Financial Analysis
    • 7.2.3Segmental and Regional Analysis
    • 7.2.4Research & Development Expense
    • 7.2.5SWOT Analysis
  • 7.3Eisai Co., Ltd.
    • 7.3.1Company Overview
    • 7.3.2Financial Analysis
    • 7.3.3Segmental and Regional Analysis
    • 7.3.4Research & Development Expenses
    • 7.3.5SWOT Analysis
  • 7.4Cayman Chemical Company, Inc.
    • 7.4.1Company Overview
    • 7.4.2Recent strategies and developments:
      • 7.4.2.1Acquisition and Mergers:
    • 7.4.3SWOT Analysis
  • 7.5Excelvite SDN. BHD.
    • 7.5.1Company Overview
    • 7.5.2SWOT Analysis
  • 7.6BTSA BIOTECNOLOGIAS APLICADAS S.L.
    • 7.6.1Company Overview
  • 7.7American River Nutrition, LLC
    • 7.7.1Company Overview
    • 7.7.2SWOT Analysis
  • 7.8Vance Group Ltd.
    • 7.8.1Company Overview
    • 7.8.2SWOT Analysis
  • 7.9Kuala Lumpur Kepong Berhad (Davos Life Science)
    • 7.9.1Company Overview
    • 7.9.2Financial Analysis
    • 7.9.3Segmental and Regional Analysis
    • 7.9.4Research & Development Expenses
    • 7.9.5Recent strategies and developments:
      • 7.9.5.1Acquisition and Mergers:
    • 7.9.6SWOT Analysis
  • 7.10.SourceOne Global Partners
    • 7.10.1Company Overview
    • 7.10.2SWOT Analysis

LIST OF TABLES

  • TABLE 1North America Tocotrienol Market, 2019 - 2022, USD Thousands
  • TABLE 2North America Tocotrienol Market, 2023 - 2030, USD Thousands
  • TABLE 3North America Tocotrienol Market, by Product, 2019 - 2022, USD Thousands
  • TABLE 4North America Tocotrienol Market, by Product, 2023 - 2030, USD Thousands
  • TABLE 5North America Alpha Market, by Country, 2019 - 2022, USD Thousands
  • TABLE 6North America Alpha Market, by Country, 2023 - 2030, USD Thousands
  • TABLE 7North America Beta Market, by Country, 2019 - 2022, USD Thousands
  • TABLE 8North America Beta Market, by Country, 2023 - 2030, USD Thousands
  • TABLE 9North America Gamma Market, by Country, 2019 - 2022, USD Thousands
  • TABLE 10North America Gamma Market, by Country, 2023 - 2030, USD Thousands
  • TABLE 11North America Delta Market, by Country, 2019 - 2022, USD Thousands
  • TABLE 12North America Delta Market, by Country, 2023 - 2030, USD Thousands
  • TABLE 13North America Tocotrienol Market, by End-use, 2019 - 2022, USD Thousands
  • TABLE 14North America Tocotrienol Market, by End-use, 2023 - 2030, USD Thousands
  • TABLE 15North America Dietary Supplements Market, by Country, 2019 - 2022, USD Thousands
  • TABLE 16North America Dietary Supplements Market, by Country, 2023 - 2030, USD Thousands
  • TABLE 17North America Pharmaceuticals Market, by Country, 2019 - 2022, USD Thousands
  • TABLE 18North America Pharmaceuticals Market, by Country, 2023 - 2030, USD Thousands
  • TABLE 19North America Cosmetics Market, by Country, 2019 - 2022, USD Thousands
  • TABLE 20North America Cosmetics Market, by Country, 2023 - 2030, USD Thousands
  • TABLE 21North America Others Market, by Country, 2019 - 2022, USD Thousands
  • TABLE 22North America Others Market, by Country, 2023 - 2030, USD Thousands
  • TABLE 23North America Tocotrienol Market, by Country, 2019 - 2022, USD Thousands
  • TABLE 24North America Tocotrienol Market, by Country, 2023 - 2030, USD Thousands
  • TABLE 25US Tocotrienol Market, 2019 - 2022, USD Thousands
  • TABLE 26US Tocotrienol Market, 2023 - 2030, USD Thousands
  • TABLE 27US Tocotrienol Market, by Product, 2019 - 2022, USD Thousands
  • TABLE 28US Tocotrienol Market, by Product, 2023 - 2030, USD Thousands
  • TABLE 29US Tocotrienol Market, by End-use, 2019 - 2022, USD Thousands
  • TABLE 30US Tocotrienol Market, by End-use, 2023 - 2030, USD Thousands
  • TABLE 31Canada Tocotrienol Market, 2019 - 2022, USD Thousands
  • TABLE 32Canada Tocotrienol Market, 2023 - 2030, USD Thousands
  • TABLE 33Canada Tocotrienol Market, by Product, 2019 - 2022, USD Thousands
  • TABLE 34Canada Tocotrienol Market, by Product, 2023 - 2030, USD Thousands
  • TABLE 35Canada Tocotrienol Market, by End-use, 2019 - 2022, USD Thousands
  • TABLE 36Canada Tocotrienol Market, by End-use, 2023 - 2030, USD Thousands
  • TABLE 37Mexico Tocotrienol Market, 2019 - 2022, USD Thousands
  • TABLE 38Mexico Tocotrienol Market, 2023 - 2030, USD Thousands
  • TABLE 39Mexico Tocotrienol Market, by Product, 2019 - 2022, USD Thousands
  • TABLE 40Mexico Tocotrienol Market, by Product, 2023 - 2030, USD Thousands
  • TABLE 41Mexico Tocotrienol Market, by End-use, 2019 - 2022, USD Thousands
  • TABLE 42Mexico Tocotrienol Market, by End-use, 2023 - 2030, USD Thousands
  • TABLE 43Rest of North America Tocotrienol Market, 2019 - 2022, USD Thousands
  • TABLE 44Rest of North America Tocotrienol Market, 2023 - 2030, USD Thousands
  • TABLE 45Rest of North America Tocotrienol Market, by Product, 2019 - 2022, USD Thousands
  • TABLE 46Rest of North America Tocotrienol Market, by Product, 2023 - 2030, USD Thousands
  • TABLE 47Rest of North America Tocotrienol Market, by End-use, 2019 - 2022, USD Thousands
  • TABLE 48Rest of North America Tocotrienol Market, by End-use, 2023 - 2030, USD Thousands
  • TABLE 49Key Information - Parchem Fine and Specialty Chemicals, Inc.
  • TABLE 50Key Information - BASF SE
  • TABLE 51Key Information - Eisai Co., Ltd.
  • TABLE 52Key Information - Cayman Chmeical Company, Inc.
  • TABLE 53Key Information - Excelvite SDN. BHD.
  • TABLE 54Key Information - BTSA BIOTECNOLOGIAS APLICADAS S.L.
  • TABLE 55Key Information - American River Nutrition, LLC
  • TABLE 56Key Information - Vance Group Ltd.
  • TABLE 57Key Information - Kuala Lumpur Kepong Berhad
  • TABLE 58Key Information - SourceOne Global Partners
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!